tobacco pipe parts nyt of the Year 2023 NWMP (78/125) (Rock Maple Inserts) Pipe File:Tobacco pipe parts.svg - Wikimedia

We also are proposing that, to determine whether to apply reweighting to the affected performance category(ies), we will consider: whether the MIPS eligible clinician knew or had reason to know of the issue with its third party intermediary's submission of the clinician's data for the performance category(ies)

Log In to react to this comment.ReplyCancel Mark S on September 22, 2019 Very good observations

Additionally, there may be cases where a drug was first approved or licensed on or before December 1, 2020, but with a first marketed date after December 1, 2020, and the drug lacks ASP or WAC data to calculate the payment amount for the applicable calendar quarter beginning July 1, 2021

It seems like a smart designe and looks unique